Precigen Inc PGEN 深 沪
已收盘 04-02 16:00:00 美东时间
3.94
+0.010
+0.25%
华盛通- 最 高4.03
- 今 开3.86
- 成交量 545.80万股
- 最 低 3.75
- 昨 收 3.93
- 总市值 13.94亿
- 52周最高 5.465
- 市盈率 静 --
- 换手率 1.54%
- 52周最低 1.225
- 委 比 -45.70%
- 总股本 3.54亿
- 历史最高 69.2096
- 量 比 0.44
- 振 幅 7.12%
- 历史最低 0.6513
- 每 手 1
- 风险率 1.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股牛股 | 药企并购潮来袭！Apellis制药飙升135%，获生化基因公司高额溢价收购；CNTA大涨44%
药企并购潮来袭！Apellis制药飙升135%，获生化基因公司高额溢价收购；CNTA大涨44%，获礼来收购，减肥药巨头转向睡眠健康领域>>
04-01 16:10
Precigen CEO, CCO join H.C. Wainwright virtual fireside chat
Precigen CEO, CCO join H.C. Wainwright virtual fireside chat Precigen executives will join virtual fireside chat with H.C. Wainwright on March 31, 2026, scheduled for 11:00 a.m.-12:00 p.m. ET. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intellige
03-30 20:32
美股牛股 | 绩优股成避风港！AI软件股Navan暴涨43%；无人机公司Swarmer大涨逾15%
绩优股成避风港！AI软件股Navan暴涨43%、Precigen涨超25%；中东局势再生变数！无人机公司Swarmer隔夜大涨15%>>
03-27 19:20
美股大行评级 | 大摩、高盛上调Denali Therapeutics目标价；Chewy、沛齐遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Atossa Therapeutics"买入"评级，目标价从7美元升至25美元；Needham：维持Nkarta"买入"评级，目标价从10美元升至11美元
03-27 10:22
Olaplex, Kodiak Sciences, Precigen And Other Big Stocks Moving Higher On Thursday
Olaplex Holdings shares surge 51% after being acquired by Henkel AG & Co. KGaA. Other big gainers include Kodiak Sciences Inc and Precigen Inc.
03-26 22:04
HC Wainwright & Co. Maintains Buy on Precigen, Raises Price Target to $10
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Precigen (NASDAQ:PGEN) with a Buy and raises the price target from $9 to $10.
03-26 20:41
Precigen shares are trading higher after the company reported better-than-expected Q4 EPS results.
Precigen shares are trading higher after the company reported better-than-expec...
03-26 20:18
Why Navan Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
Shares of Navan Inc (NASDAQ: NAVN) spiked in pre-market trading on better-than-expected Q4 results. Gainers include EEIQ, FCHL, OLPX, SLND, PGEN, EDHL, NFGC, NEXT, and VG. Losers include MGN, CBUS, HUBC, and UGRO.
03-26 17:47
电话会总结 ｜ Precigen(PGEN)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Precigen业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 2025财年总收入970万美元，较2024财年320万美元增长149% - 净产品收入340万美元，主要来自2025年11月开始的Papzimius商业化销售 - Q4净产品收入340万美元（仅反映11月开始的部分季度销售） **盈利状况：** - 归属于普通股股东的净亏损4.296亿美元，每股亏损1.37美元 - 净亏损中包含3.185亿美元（每股1.02美元）的优先股认股权证相关非现金费用 **现金状况：** - 年末现金、现金等价物及投资总额
03-26 12:09
Precigen Q4 EPS $(0.01) Beats $(0.08) Estimate, Sales $4.565M Miss $8.286M Estimate
Precigen (NASDAQ:PGEN) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.08) by 87.95 percent. This is a 83.33 percent increase over losses of $(0.06) per share from the same
03-26 04:10
